Quantcast

Latest Darbepoetin alfa Stories

2008-11-25 11:59:01

Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, U.S. researchers say.

2008-11-13 09:00:37

Affymax, Inc. (Nasdaq:AFFY) today announced that enrollment has been completed in EMERALD 1, one of its Phase 3 clinical trials of its lead investigational therapy, Hematide(TM), which is being evaluated for the treatment of anemia in chronic renal failure patients.

2008-11-07 12:00:23

Affymax, a biopharmaceutical company, has announced positive results from a long-term safety and effectiveness study of its lead investigational therapy, Hematide, which is being evaluated for the treatment of anemia in chronic renal failure patients.

2008-11-03 06:00:21

Medgenics (AIM:MEDG), is pleased to announce encouraging preliminary data for its Phase I/II clinical trial. The landmark Phase I/II clinical trial of Medgenics' EPODURE Biopump, for providing sustained treatment of anemia in subjects with chronic kidney disease, is underway.

2008-09-29 12:00:40

The U.S. Food and Drug Administration issued an advisory about preliminary results of a German study involving the drug known as Procrit, Eprex or Epogen.

2008-07-11 18:00:35

Amgen (NASDAQ:AMGN) today announced that it has reached an agreement to settle its outstanding antitrust litigation with Ortho Biotech Products L.P. (Ortho Biotech).

2008-07-10 12:01:17

Affymax has completed enrollment in the first of four Phase III clinical trials of its lead investigational therapy, Hematide, which is being evaluated for the treatment of anemia in chronic renal failure patients.

2008-07-09 09:01:01

Affymax, Inc. (Nasdaq:AFFY) today announced that enrollment has been completed in the first of four Phase 3 clinical trials of its lead investigational therapy, Hematide(TM), which is being evaluated for the treatment of anemia in chronic renal failure patients.

2008-06-30 09:03:37

Affymax, Inc. (Nasdaq:AFFY) today announced that enrollment has begun in a Phase 2 clinical trial of Hematide(TM) to correct anemia in patients with chronic renal failure (CRF) who are undergoing dialysis and are not actively being treated with an erythropoiesis stimulating agent (ESA).


Word of the Day
pudic
  • Easily ashamed, having a strong sense of shame; modest; chaste.
  • Of or pertaining to the external organs of generation.
The word 'pudic' comes from French pudique, from Latin pudīcus, from pudet ("it shames"). (Wiktionary)
Related